Eidogen-Sertanty to Partner with Accelrys on Kinase Database Offering

San Diego, CA (July 9, 2009) – Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, today announced the expansion of its partnership with Accelrys, Inc. (NASDAQ: ACCL) to enhance the Kinase Knowledgebase through advanced visualization and computational tools.

As an ISV partner to Accelrys supporting its Pipeline Pilot™ and Discovery Studio® platforms, Eidogen-Sertanty will now offer its small molecule knowledgebase the Kinase Knowledgebase (KKB) through the Accelrys Kinome Viewer.

The Accelrys Kinome Viewer is a solution designed to facilitate small molecule drug discovery for kinase targets. Built upon Pipeline Pilot, the premier platform for the integration, analysis, and reporting of scientific data, the Kinome viewer enables a researcher to associate biological, chemical, and computational information on a single map. Activity and selectivity profiles of the compounds can be readily automated and visualized with information on target series, ligand binding data, and compound series - all within one customizable interface.

The Kinase Knowledgebase is Eidogen-Sertanty's database of structure-activity relationship (SAR) and chemical synthesis data focused on protein kinases. The KKB is released quarterly and currently contains over 402,000 data points curated from over 5,600 peer-reviewed journal articles and patents.

Offered on a variety of platforms, including Accelrys Pipeline Pilot, Daylight's Daycart, Symyx's-ISIS, and in ASCII formats, by extending access through the Kinome Viewer, the Kinase Knowledgebase can be mined more rapidly by larger numbers of researchers.

Eidogen-Sertanty contact:

Steve Muskal
760-729-0211
pr@eidogen-sertanty.com

Accelrys Contact:

Maria Krinsky
Kickstart for Accelrys
(415) 509-0498
mkrinsky@kickstartconsulting.com

About Eidogen-Sertanty, Inc.
Eidogen-Sertanty, formed in March 2005 from the merger of Eidogen and Sertanty, is a privately held company providing pioneering knowledge-driven discovery solutions to biotechnology and pharmaceutical organizations.  Eidogen-Sertanty’s unique and powerful suite of software, databases, and drug discovery services enable customers and collaborators to apply a knowledge-driven discovery approach to a variety of workflows and processes, including target selection and prioritization, library building and compound prioritization, and lead design and optimization.  To find out more about Eidogen-Sertanty and their products and services please visit www.eidogen-sertanty.com.

About Accelrys, Inc.
Headquartered in San Diego, California, Accelrys develops scientific business intelligence software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries. Customers include many Fortune 500 companies and other commercial entities, as well as academic and government entities. Accelrys has a vast portfolio of computer-aided design modeling and simulation offerings which assist customers in conducting scientific experiments 'in silico' in order to reduce the duration and cost of discovering and developing new drugs and materials. Its scientific business intelligence platform underlies the company's computer-aided design modeling and simulation offerings. The Accelrys platform can be used with both Accelrys and competitive products, as well as with customers' proprietary predictive science products. Its flexibility, ease-of-use and advanced chemical, text and image analysis and reporting capabilities enable customers to mine, aggregate, analyze and report scientific data from disparate sources, thereby better utilizing scientific data within their organizations. For more information about Accelrys, visit http://accelrys.com/